Literature DB >> 329529

Retinal neovascularization in sickle cell retinopathy.

M F Goldberg.   

Abstract

Neovascularization of the retina occurs in several types of sickle cell hemoglobinopathies and is highly characteristic in appearance. It arises in the equatorial plane of the fundus following preliminary arteriolar occlusions and arteriolar-venular anastomoses. Neovascular sea fans arise at the interface of perfused and nonperfused portions of the retina, starting during the first decade of life and continuing for many years thereafter. Although some sea fans undergo spontaneous autoinfarction, most show progressive growth and constant intravitreal transudation of plasma components. Traction on the sea fans and the retina results in bleeding into the vitreous, retinal tears, and retinal detachment. Therapeutic intervention with a variety of coagulative techniques is feasible and is usually indicated whenever sea fans are discovered. All therapeutic modalities are capable of inducing significant complications. This is particularly true of argon laser photocoagulation when energy is concentrated into small areas (less than 200 mu) for short durations (less than 0.2 second). With appropriate precautions, photocoagulation results in a high rate of successful obliteration of neovascular tissue. Both vitrectomy and scleral buckling are valuable therapeutic procedures, but both have disproportionately high complication rates in eyes with the propensity for intravascular sickling of erythrocytes. Specific prophylactic measures are therefore indicated when these operative techniques are employed in patients with sickle cell diseases.

Entities:  

Mesh:

Year:  1977        PMID: 329529

Source DB:  PubMed          Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol        ISSN: 0161-6978


  6 in total

1.  Neutrophils and leucocyte adhesion molecules in sickle cell retinopathy.

Authors:  M Kunz Mathews; D S McLeod; C Merges; J Cao; G A Lutty
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

2.  Analysis of Retinal Thinning Using Spectral-domain Optical Coherence Tomography Imaging of Sickle Cell Retinopathy Eyes Compared to Age- and Race-Matched Control Eyes.

Authors:  Jennifer I Lim; Dingcai Cao
Journal:  Am J Ophthalmol       Date:  2018-03-17       Impact factor: 5.258

Review 3.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

4.  Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report.

Authors:  Panagiotis G Mitropoulos; Irini P Chatziralli; Efstratios A Parikakis; Vasileios G Peponis; Georgios A Amariotakis; Marilita M Moschos
Journal:  Case Rep Ophthalmol Med       Date:  2014-11-23

5.  Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy.

Authors:  Kathleen Jee; Murilo Rodrigues; Fabiana Kashiwabuchi; Brooks P Applewhite; Ian Han; Gerard Lutty; Morton F Goldberg; Gregg L Semenza; Silvia Montaner; Akrit Sodhi
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

6.  Risk factors associated with sickle cell retinopathy: findings from the Cooperative Study of Sickle Cell Disease.

Authors:  Mohammed Nawaiseh; Allaa Roto; Yara Nawaiseh; Mohammad Salameh; Rund Haddadin; Lana Mango; Hussam Nawaiseh; Doha Alsaraireh; Qais Nawaiseh; Saif Aldeen AlRyalat; Amer Alwreikat; David J Ramsey; Nakhleh Abu-Yaghi
Journal:  Int J Retina Vitreous       Date:  2022-09-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.